abagovomab 33
abciximab 27
abituzumab 15
abrilumab 15
actoxumab 20
adalimumab 9
aducanumab 11
afasevikumab 3
alacizumab_pegol 6
alemtuzumab 37
alirocumab 14
amatuximab 37
andecaliximab 24
anifrolumab 22
anrukinzumab 14
aprutumab 15
aprutumab_ixadotin 15
arcitumomab 14
ascrinvacumab 11
atezolizumab 10
atinumab 17
avelumab 13
basiliximab 32
bavituximab 25
begelomab 21
benralizumab 19
bevacizumab_beta 16
bezlotoxumab 20
bimagrumab 10
bleselumab 23
blinatumomab 32
blosozumab 29
bococizumab 23
brazikumab 14
brentuximab_vedotin 25
briakinumab 14
brodalumab 12
brolucizumab 20
brontictuzumab 26
burosumab 21
cabiralizumab 25
camrelizumab 14
canakinumab 19
cantuzumab_ravtansin 33
carlumab 18
carotuximab 8
cergutuzumab_amunaleukin2 31
cergutuzumab_amunaleukin 31
certolizumab_pegol 22
cetiximab 32
citatuzumab_bogatox 25
cixutumumab 24
clivatuzumab_tetraxetan 21
codrituzumab 23
conatumumab 20
concizumab 14
crenezumab 15
crizanlizumab 22
crotedumab 19
dacetuzumab 22
daclizumab 18
dalotuzumab 30
dapirolizumab_pegol 25
daratumumab 13
dectrekumab 9
demcizumab 25
denosumab 7
depatuxizumab 25
depatuxizumab_mafodotin 25
dezamizumab 21
dinutuximab 31
diridavumab 21
domagrozumab 11
drozitumab 17
duligotuzumab 20
durvalumab 13
dusigitumab 27
efalizumab 33
efungumab 18
eldelumab 17
elezanumab 19
elgemtumab 4
elotuzumab 15
emactuzumab 20
emapalumab 18
emibetuzumab 20
enavatuzumab 24
enfortumab_vedotin 10
enoblituzumab 17
enokizumab 28
enoticumab 20
ensituximab 30
eptinezumab 9
erenumab 21
etaracizumab 12
etrolizumab 19
evinacumab 17
evolocumab 16
farletuzumab 0
fasinumab 24
fezakinumab 21
fibatuzumab 15
ficlatuzumab 29
firivumab 27
flanvotumab 19
fletikumab 33
foralumab 15
foravirumab 14
fremanezumab 24
fresolimumab 15
fulranumab 15
futuximab 16
galcanezumab 15
ganitumab 25
gantenerumab 14
gemetuzumab 30
gemtuzumab2 26
gemtuzumab 12
gevokizumab 24
girentuximab 24
glembatumumab 24
glembatumumab_vedotin 24
guselkumab 20
ibalizumab 25
ibritumomab 29
icrucumab 15
idarucizumab 31
ifabotuzumab 15
imalumab 11
imgatuzumab 24
inclacumab 16
indatuximab_ravtansin 30
indusatumab 18
inebilizumab 22
intetumumab 13
iodine_girentuximab 21
ipilimumab 4
iratumumab 19
isatuximab 29
itolizumab 17
ixekizumab 24
labetuzumab_govitecan 24
lambrolizumab 26
lampalizumab 26
lanadelumab 19
landogrozumab 16
laprituximab 25
lebrikizumab 29
lendalizumab 31
lenzilumab 21
lifastuzumab_vedotin 16
ligelizumab 21
lilotomab 31
lirilumab 25
lodelcizumab 19
lokivetmab 12
lorvotuzumab_mertansin 15
lucatumumab 28
lumretuzumab 19
lupartumab 13
lutikizumab 12
margetuximab 30
milatuzumab 18
mirvetuximab 34
mirvetuximab_soravtansin 34
modotuximab 34
mogamulizumab 18
monalizumab 23
motavizumab 31
moxetumomab_pasudotox 14
namilumab 20
naratuximab 32
naratuximab_emtansin 32
narnatumab 16
navicixizumab2 27
navicixizumab 25
navivumab 15
necitumumab 19
nemolizumab 29
nesvacumab 14
nivolumab 17
obiltoxaximab 17
obinutuzumab 28
ocaratuzumab 22
ofatumumab 14
olaratumab 19
olokizumab 21
omalizumab 16
onartuzumab 22
ontuxizumab 19
opicinumab 13
orticumab 9
otelixizumab 25
oxelumab 8
ozanezumab 21
pamrevlumab 7
panobacumab 19
parsatuzumab 28
pasotuxizumab 16
pateclizumab 17
patritumab 26
pembrolizumab 26
perakizumab 20
pidilizumab 14
pinatuzumab_vedotin 17
plozalizumab 13
pogalizumab 26
polatuzumab_vedotin 19
ponezumab 26
prezalumab 14
pritoxaximab 31
quilizumab 16
racotumomab 22
radretumab 11
ralpancizumab 27
ramucirumab 9
ranevetmab 29
ranibizumab 13
refanezumab 18
remtolumab 10
rilotumumab 24
rinucumab 16
risankizumab 31
rituximab 18
rivabazumab 23
robatumumab 19
roledumab 17
romosozumab 21
rontalizumab 26
rosmantuzumab 17
rozanolixizumab 18
sacituzumab 28
sacituzumab_govitecan 28
samalizumab 26
sapelizumab 19
sarilumab 9
secukinumab 18
seribantumab 16
setoxaximab 29
sifalimumab 15
siltuximab 12
simtuzumab 30
sirukumab 9
solanezumab 22
solitomab 22
stamulumab 20
suptavumab 24
suvizumab 20
tabalumab 15
tadocizumab 20
tamtuvetmab 28
tanezumab 26
tarextumab 9
tavolixizumab 11
telisotuzumab 28
teplizumab 17
tesidolumab 27
tezepelumab 29
tigatuzumab 13
tildrakizumab 20
timolumab 12
tisotumab 9
tosatoxumab 28
tositumomab 26
tralokinumab 31
trastuzumab 25
tregalizumab 19
trevogrumab 8
ublituximab 29
urelumab 22
ustekinumab 22
utomilumab 22
vadastuximab 21
vadastuximab_talirin 21
vandortuzumab_vedotin 18
vantictumab 25
vanucizumab2 16
vanucizumab 25
varlilumab 18
vatelizumab 24
vedolizumab 18
veltuzumab 23
vesencumab 8
vorsetuzumab 26
vorsetuzumab_mafodotin 26
vunakizumab 30
xentuzumab 17
zatuximab 34
